Epigenetic modifications in gastric cancer: Focus on DNA methylation

被引:63
作者
Ebrahimi, Vida [1 ,2 ]
Soleimanian, Alireza [1 ,3 ]
Ebrahimi, Tahereh [4 ]
Azargun, Robab [5 ]
Yazdani, Parivar [1 ]
Eyvazi, Shirin [6 ]
Tarhriz, Vahideh [1 ]
机构
[1] Tabriz Univ Med Sci, Mol Med Res Ctr, Biomed Inst, Tabriz, Iran
[2] Shahid Beheshti Univ Med Sci, Sch Pharm, Dept Pharmaceut Biotechnol, Tehran, Iran
[3] Univ Tabriz, Fac Nat Sci, Dept Biol, Tabriz, Tabriz, Iran
[4] Pasteur Inst Iran, Res Ctr, Dept NanoBiotechnol, Tehran, Iran
[5] Maragheh Univ Med Sci, Fac Med, Dept Microbiol, Maragheh, Iran
[6] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Biotechnol, Tehran, Iran
关键词
Gastric cancer; Epigenetics alterations; DNA methylation; TUMOR-SUPPRESSOR; PROMOTER METHYLATION; GENE METHYLATION; POOR SURVIVAL; E-CADHERIN; DIFFUSE; CARCINOGENESIS; METASTASIS; INVASION; PROLIFERATION;
D O I
10.1016/j.gene.2020.144577
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Gastric cancer is a complex heterogeneous disease which is the fourth prevalent malignancy worldwide. Although, several diagnosis and treatment are available for the gastric cancer patients, however the malignancy is still the third leading cause of cancer-related death in the world. Beside the genetic and environmental factors, epigenetic alterations are also involved in the emergence of gastric cancer. Epigenetics alterations are heritable changes which regulate gene expression without occurring changes in DNA sequence. Epigenetic changes mostly include DNA methylation, histon post-translational modifications, chromatin remodeling and non-coding RNAs. Among the mentioned epigenetic modifications, DNA methylation is a major epigenetic process that plays a key role in different stages of evolution and cancer development. In this review, we address all types of related epigenetic modifications in gastric cancer by focus on DNA methylation by reviewing the recent literatures. Understanding of molecular mechanisms of epigenetics alterations in gastric cancer development helps researchers to identify new epigenetic drugs against the malignancy.
引用
收藏
页数:7
相关论文
共 70 条
  • [1] [Anonymous], [No title captured]
  • [2] [Anonymous], [No title captured]
  • [3] [Anonymous], [No title captured]
  • [4] [Anonymous], [No title captured]
  • [5] [Anonymous], [No title captured]
  • [6] [Anonymous], [No title captured]
  • [7] Potential role of chromatin remodeling factor genes in atrophic gastritis/gastric cancer risk
    Bilgic, Fahri
    Gerceker, Emre
    Boyacioglu, Seda Orenay
    Kasap, Elmas
    Demirci, Ufuk
    Yildinm, Hatice
    Baykan, Ahmed Ramiz
    Yuceyar, Hakan
    [J]. TURKISH JOURNAL OF GASTROENTEROLOGY, 2018, 29 (04) : 427 - 435
  • [8] Role of histone acetylation in gastric cancer: implications of dietetic compounds and clinical perspectives
    Calcagno, Danielle Q.
    Wisnieski, Fernanda
    da Silva Mota, Elizangela R.
    Maia de Sousa, Stefanie B.
    Costa da Silva, Jessica M.
    Leal, Mariana F.
    Gigek, Carolina O.
    Santos, Leonardo C.
    Rasmussen, Lucas T.
    Assumpcao, Paulo P.
    Burbano, Rommel R.
    Smith, Marilia A. C.
    [J]. EPIGENOMICS, 2019, 11 (03) : 349 - 362
  • [9] The central role of EED in the orchestration of polycomb group complexes
    Cao, Qi
    Wang, Xiaoju
    Zhao, Meng
    Yang, Rendong
    Malik, Rohit
    Qiao, Yuanyuan
    Poliakov, Anton
    Yocum, Anastasia K.
    Li, Yong
    Chen, Wei
    Cao, Xuhong
    Jiang, Xia
    Dahiya, Arun
    Harris, Clair
    Feng, Felix Y.
    Kalantry, Sundeep
    Qin, Zhaohui S.
    Dhanasekaran, Saravana M.
    Chinnaiyan, Arul M.
    [J]. NATURE COMMUNICATIONS, 2014, 5
  • [10] Carcas, 2014, J CARCINOG, V13